CIK 0001743881 · Large accelerated filer
BridgeBio Pharma, Inc.
Sign in to watch- Ticker
- BBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (650) 391-9740
- Business address
- 3160 PORTER DR., SUITE 250, PALO ALTO, CA, 94304
- Former names
- BridgeBio Pharma LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,563,798
- in 3 filings, $4.6M under 10b5-1 plans
Net −$4,563,798. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-16 | STEPHENSON BRIAN C Secretary, Treasurer & CFO | Option exercise · Restricted Stock Units 10b5-1 | −946 | 2,840 | ||
| 2025-02-16 | STEPHENSON BRIAN C Secretary, Treasurer & CFO | Option exercise · Restricted Stock Units 10b5-1 | −17,368 | 138,947 | ||
| 2025-02-16 | STEPHENSON BRIAN C Secretary, Treasurer & CFO | Option exercise · Restricted Stock Units 10b5-1 | −6,705 | 80,459 | ||
| 2025-02-16 | Kumar Neil Chief Executive Officer | Option exercise 10b5-1 | +55,539 | 267,257 | ||
| 2025-02-16 | Kumar Neil Chief Executive Officer | Shares withheld for taxes 10b5-1 | −23,996 | $34.90 | $837K | 243,261 |
| 2025-02-16 | Kumar Neil Chief Executive Officer | Option exercise · Restricted Stock Units 10b5-1 | −2,395 | 0 | ||
| 2025-02-16 | Kumar Neil Chief Executive Officer | Option exercise · Restricted Stock Units 10b5-1 | −33,544 | 268,352 | ||
| 2025-02-16 | Kumar Neil Chief Executive Officer | Option exercise · Restricted Stock Units 10b5-1 | −19,600 | 235,191 | ||
| 2025-01-31 | VIKING GLOBAL INVESTORS LP 10% owner | Sale | −3,065,616 | $34.90 | $107.0M | 22,055,375 |
| 2025-01-29 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −269,068 | $36.34 | $9.8M | 5,102,447 |
| 2025-01-29 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −4,000 | $36.82 | $147K | 5,098,447 |
| 2025-01-28 | STEPHENSON BRIAN C Secretary, Treasurer & CFO | Option exercise 10b5-1 | +68,000 | $17.00 | $1.2M | 161,758 |
| 2025-01-28 | STEPHENSON BRIAN C Secretary, Treasurer & CFO | Sale 10b5-1 | −68,000 | $36.29 | $2.5M | 93,758 |
| 2025-01-28 | STEPHENSON BRIAN C Secretary, Treasurer & CFO | Option exercise · Stock Option (right to buy) 10b5-1 | −68,000 | 448,670 | ||
| 2025-01-28 | Kumar Neil Chief Executive Officer | Sale 10b5-1 | −326,932 | $36.29 | $11.9M | 5,371,515 |
| 2024-12-30 | Satvat Ali J. Director | Option exercise | +79,702 | $10.99 | $876K | 79,702 |
| 2024-12-30 | Satvat Ali J. Director | Option exercise | +39,851 | $16.68 | $665K | 119,553 |
| 2024-12-30 | Satvat Ali J. Director | Option exercise | +39,851 | $26.21 | $1.0M | 159,404 |
| 2024-12-30 | Satvat Ali J. Director | Option exercise · Stock Option (Right to Buy) | −79,702 | 0 | ||
| 2024-12-30 | Satvat Ali J. Director | Option exercise · Stock Option (Right to Buy) | −39,851 | 0 |
Page 21 of 32 · 638 trades